From professional translators, enterprises, web pages and freely available translation repositories.
gastroduodenal ulceration, gastrooesophageal reflux disease, dry mouth, gastrointestinal sounds abnormal
ulċerazzjoni gastro- duwodenali, mard ta’ rifluss gastro-esofagali, ħalq xott, ħsejjes gastro- intestinali mhux normali
helicobacter test infai may be used for in vivo diagnosis of gastroduodenal helicobacter pylori infection in:
helicobacter test infai jista ’ jintuża għal dijanjosi in vivo ta ’ infezzjoni b’ helicobacter pylori fl - istonku u l- imsaren f ’:
helicobacter test infai for children aged 3 to 11 years may be used for in vivo diagnosis of gastroduodenal helicobacter pylori infection:
helicobacter test infai għal tfal bejn l- etajiet ta ’ 3 snin sa 11- il sena jista ’ jintuża għal dijanjosi in vivo ta 'infezzjoni b' helicobacter pylori li jinsab fl- istonku u l- imsaren.
helicobacter test infai for children of the age 3-11 may be used for in vivo diagnosis of gastroduodenal helicobacter pylori infection:
helicobacter test infai għal tfal bejn l-etajiet ta’ 3 snin sa 11-il sena jista’ jintuża għal dijanjosi in vivo ta' infezzjoni b' helicobacter pylori li jinsab fl-istonku u l-imsaren.
duoplavin should be used with caution in patients with a history of peptic ulcer or gastroduodenal haemorrhage or minor upper gi symptoms as this may be due to gastric ulceration which may lead to gastric bleeding.
duoplavin għandu jintuża b’kawtela f’pazjenti b’passat mediku ta’ ulċera peptika jew emorraġija gastro-dwodenali jew b’sintomi ħfief li juru xi disturbi fl-istonku jew ta’ parti ta’ fuq ta’ l-imsaren għax dan jista’ jkun minħabba ulċerazzjoni gastrika li tista’ twassal għal emorraġija gastrika.
clopidogrel/acetylsalicylic acid zentiva should be used with caution in patients with a history of peptic ulcer or gastroduodenal haemorrhage or minor upper gi symptoms as this may be due to gastric ulceration which may lead to gastric bleeding.
clopidogrel/acetylsalicylic acid zentiva għandu jintuża b’kawtela f’pazjenti b’passat mediku ta’ ulċera peptika jew emorraġija gastro-dwodenali jew b’sintomi ħfief li juru xi disturbi fl-istonku jew ta’ parti ta’ fuq ta’ l-imsaren għax dan jista’ jkun minħabba ulċerazzjoni gastrika li tista’ twassal għal emorraġija gastrika.
the combination of clopidogrel/acetylsalicylic acid should be used with caution in patients with a history of peptic ulcer or gastroduodenal haemorrhage or minor upper gi symptoms as this may be due to gastric ulceration which may lead to gastric bleeding.
il-kombinazzjoni ta’ clopidogrel/acetylsalicylic acid għandha tintuża b’kawtela f’pazjenti b’passat mediku ta’ ulċera peptika jew emorraġija gastro-dwodenali jew b’sintomi ħfief li juru xi disturbi fl- istonku jew ta’ parti ta’ fuq tal-imsaren għax dan jista’ jkun minħabba ulċerazzjoni gastrika li tista’ twassal għal emorraġija gastrika.
in dogs, prucalopride alters colonic motility patterns via serotonin 5-ht4 receptor stimulation: it stimulates proximal colonic motility, enhances gastroduodenal motility and accelerates delayed gastric emptying.
fil-klieb, prucalopride jibdel il-mudelli ta’ motilità tal-kolon permezz ta’ stimulazzjoni tar-riċettur 5-ht4 ta’ serotonin: hu jistimula l-motilità prossimali tal-kolon, iżid il-motilità gastroduwodenali u jaċċellera t-tbattil gastriku ttardjat.
the committee for medicinal products for human use (chmp) decided that pylobactell’ s benefits are greater than its risks for the in vivo diagnosis of gastroduodenal h. pylori infection.
il- kumitat għall- prodotti mediċinali għall- użu mill- bniedem (chmp) iddeċieda li l- benefiċċji ta 'pylobactell huma ogħla mir- riskji tiegħu fid- dijanjożi in vivo ta' l- infezzjoni gastroduwodenali minn h. pylori.
additional gastrointestinal safety data in two 12-week double-blind endoscopy studies, the cumulative incidence of gastroduodenal ulceration was significantly lower in patients treated with etoricoxib 120 mg once daily than in patients treated with either naproxen 500 mg twice daily or ibuprofen 800 mg three times daily.
23 tagħrif addizzjonali dwar is- sigurtà gastrointestinali f’ żewġ studji ta ’ endoskopija double- blind ta ’ 12- il ġimgħa, l- inċidenza kumulattiva ta ’ ulċerazzjoni gastroduwodenali kienet ferm inqas fil- pazjenti kkurati b’ etoricoxib 120 mg darba kuljum milli f’ pazjenti kkurati jew b’ naproxen 500 mg darbtejn kuljum jew b’ ibuprofen 800 mg tliet darbiet kuljum.